Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AACCURAY INC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

ACCURAY INC

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

News

News

  • AI in Radiation Oncology: What It Takes to Deploy Responsibly
    Mar 16, 2026Accuray

    In January 2026, Unicancer hosted a day-long course on artificial intelligence in radiation oncology at the Geneva Innovation Hub in Genolier, Switzerland. Endorsed by ESTRO and ASTRO, sponsored by Accuray, the program drew attendees from 24 countries. “Clinical deployment is often faster than collective understanding,” said Dr. Arnaud Beddok, a radiation oncologist at Institut Godinot […] The post AI in Radiation Oncology: What It Takes to Deploy Responsibly appeared first on Accuray.

  • WRAD: Celebrating Over a Year of Global Radiotherapy Advocacy
    Feb 9, 2026Accuray

    On September 7th, 2025, the global radiotherapy community united for the first-everWorld Radiotherapy Awareness Day (WRAD)—a milestone event dedicated to spotlighting the crucial role of radiotherapy in cancer care, symptom relief, and improving patients’ quality of life. WRAD’s debut resonated worldwide, igniting conversations and collaborations across continents, and inspiring professionals, societies, and patients to share […] The post WRAD: Celebrating Over a Year of Global Radiotherapy Advocacy appeared first on Accuray.

  • Miroki: the companion robot that ensures children undergoing radiotherapy never feel alone
    Feb 1, 2026Accuray

    Around 2,300 children and adolescents are diagnosed with cancer every year in France..1 Paediatric cancers include a multitude of rare diseases whose treatment requires a multidisciplinary and personalized approach tailored to each young patient. Radiotherapy is one of the pillars of cancer treatment. It is estimated that around one in three children with cancer will […] The post Miroki: the companion robot that ensures children undergoing radiotherapy never feel alone appeared first on Accuray.

  • Going Live: Lessons from CyberKnife® System Installation in Melbourne
    Dec 9, 2025Accuray

    A Deep Dive into the Installation, Training, and Advantages of the CyberKnife System The implementation of cutting-edge technology in healthcare is never a simple process, but when executed with strategic planning and robust support, the results can be transformative. This blog explores the journey of installing the CyberKnife® System at 5D Clinics Melbourne, Australia, as […] The post Going Live: Lessons from CyberKnife® System Installation in Melbourne appeared first on Accuray.

  • Exploring the Impact of Advanced Radiosurgery on Trigeminal Neuralgia
    Oct 7, 2025Accuray

    What is trigeminal neuralgia (TN)? Trigeminal neuralgia is a chronic pain condition characterized by recurrent episodes of intense facial pain. This disorder affects the trigeminal nerve (the fifth cranial nerve), which is responsible for sensory function and neural signaling in regions of the head and face. While individual attacks often last only a few seconds, […] The post Exploring the Impact of Advanced Radiosurgery on Trigeminal Neuralgia appeared first on Accuray.

  • World Radiotherapy Awareness Day: A Call to Action to Make Radiotherapy Understood and Accessible
    Sep 4, 2025Accuray

    September 7th 2025 marks the first World Radiotherapy Awareness Day (WRAD). WRAD is a day dedicated to uniting together to highlight the essential role of radiotherapy in treating cancer, relieving symptoms, and improving quality of life for patients. Access to radiotherapy is a critical global issue More than 35 million new cancer diagnoses are predicted […] The post World Radiotherapy Awareness Day: A Call to Action to Make Radiotherapy Understood and Accessible appeared first on Accuray.

  • Highlights from the ISRS CNS Summit 2025: The CyberKnife® System’s Impact in Radiosurgery
    Jun 13, 2025Accuray

    The International Stereotactic Radiosurgery Society (ISRS) is a global community of professionals dedicated to Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT). The CNS Summit is a newly organized event by ISRS, focusing on central nervous system conditions such as spinal and skull base radiosurgery. As we delve into the findings presented at the […] The post Highlights from the ISRS CNS Summit 2025: The CyberKnife® System’s Impact in Radiosurgery appeared first on Accuray.

  • ESTRO 2025 Research Highlights
    Jun 6, 2025Accuray

    The theme for ESTRO 2025 was “Transformative Innovation Through Partnership,” emphasizing the importance of collaboration and partnership to push the boundaries of radiation oncology and multidisciplinary cancer care. The program featured interactive sessions, panel discussions, and joint sessions with partner associations, focusing on breakthrough research and innovation. The congress aimed to connect the radiotherapy community, […] The post ESTRO 2025 Research Highlights appeared first on Accuray.

  • Icon Cancer Centre and 5D Clinics: A Joint Venture to Expand Access to Advanced Radiotherapy in Australia
    Mar 21, 2025Accuray

    In a move to increase patient access to advanced radiotherapy technology, Icon Cancer Centre has partnered with 5D Clinics to bring the highly precise CyberKnife® System to the east coast of Australia. This joint venture aims to make robotic radiation therapy technology available to the greater Australian population, reducing the current need to travel long-distances […] The post Icon Cancer Centre and 5D Clinics: A Joint Venture to Expand Access to Advanced Radiotherapy in Australia appeared first on Accuray.

  • SBRT for Prostate Cancer: Understanding the Evidence of the PACE-B Trial
    Feb 27, 2025Accuray

    “Stereotactic body radiation therapy (SBRT) for patients with low and favorable intermediate risk prostate cancer should be considered a new standard of care,” reports Prof. Nicholas van As, Consultant Clinical Oncologist and Medical Director of The Royal Marsden NHS Foundation Trust. The PACE B trial has demonstrated that five-fraction SBRT is non-inferior to conventional radiotherapy […] The post SBRT for Prostate Cancer: Understanding the Evidence of the PACE-B Trial appeared first on Accuray.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • News
  • Insider Transactions
$0.30Close · Sep 28, 2026